Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Apimeds Pharmaceuticals US, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative therapies for inflammation and pain. Founded in 2020 and headquartered in Hopewell, New Jersey, we specialize in researching, developing, and commercializing Apitox, our proprietary active pharmaceutical ingredient derived from purified bee venom. Our primary focus is on treating symptoms associated with osteoarthrit...
Apimeds Pharmaceuticals US, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative therapies for inflammation and pain. Founded in 2020 and headquartered in Hopewell, New Jersey, we specialize in researching, developing, and commercializing Apitox, our proprietary active pharmaceutical ingredient derived from purified bee venom. Our primary focus is on treating symptoms associated with osteoarthritis and multiple sclerosis. Apitox's unique anti-inflammatory and pain-relieving properties position it as a promising therapeutic candidate.

List your booth number for exhibitions, ask us